Staphylococcus Aureus Endocarditis
📧 Sign up to get email alerts when something new happens for Staphylococcus Aureus Endocarditis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia [Phase 4]
A Phase 4 clinical trial compares dabigatran to oral anti-Xa inhibitors in Staphylococcus aureus bacteremia-related conditions and is curren…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia [Phase 4]
Phase 4 trial comparing clopidogrel vs aspirin for cardiovascular risk reduction in patients with Staphylococcus aureus infections; the stud…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia [Phase 4]
A Phase 4 clinical trial comparing daptomycin versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia [Phase 2]
Phase 2 clinical trial evaluating a combination of cefazolin with ertapenem for methicillin-susceptible Staphylococcus aureus bacteremia is …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus [Phase 3]
Phase 3 clinical trial evaluating adjunctive rifampin for treating prosthetic valve endocarditis caused by Staphylococcus aureus is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase [Phase 3]
Phase 3 trial of exebacase for direct lysis of Staphylococcus aureus showing terminated status with results posted.
-
CLINICAL_TRIALS withdrawal · 2022-04-06Clinical Trial Update: Oritavancin for Staphylococcus Aureus Infections in Opioid Users [Phase 4]
Phase 4 trial of oritavancin for Staphylococcus aureus infections in opioid users has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia [Phase 2]
Phase 2 trial evaluating CF-301 (oritavancin-like agent) added to antibacterial therapy for Staphylococcus aureus bacteremia and endocarditi…
-
FDA approval · 2019-11-15FDA Approved: DAPTOMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for daptomycin by Sagent Pharmaceuticals, authorizing a generic injectable form of daptomycin.